First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Clinical trial NCT03401385 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03401385
Sponsor: Daiichi Sankyo Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hormone Receptor Positive Breast Cancer Triple Negative Breast Cancer Non-small Cell Lung Cancer

Start date: 2018-01-31
Primary completion: 2027-01-01
Enrollment: 890

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.